Discovery of first-in-class multi-target adenosine A2A receptor antagonists-carbonic anhydrase IX and XII inhibitors. 8-Amino-6-aryl-2-phenyl-1,2,4-triazolo [4,3-a]pyrazin-3-one derivatives as new potential antitumor agents
Costanza Ceni(European Theoretical Spectroscopy Facility), Vittoria Colotta(University of Florence), Rosaria Volpini(Università di Camerino), Alessio Nocentini(University of Florence), Diego Dal Ben(Università di Camerino), Claudiu T. Supuran(University of Florence), Paola Gratteri(University of Florence), Michela Buccioni(Università di Camerino), Gabriella Marucci, Flavia Varano(University of Florence), Andrea Angeli(University of Florence), Daniela Catarzi(University of Florence)
Cited by 11
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5k
Interfering with pH regulation in tumours as a therapeutic strategy
|Nature Reviews Drug Discovery|2011|1.5k
How many carbonic anhydrase inhibition mechanisms exist?
|Journal of Enzyme Inhibition and Medicinal Chemistry|2015|724
Structure-based drug discovery of carbonic anhydrase inhibitors
|Journal of Enzyme Inhibition and Medicinal Chemistry|2012|608